Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant vitamin D with infliximab in active Crohn's disease (IBDVit2)
2008-001466-93Phase 4Terminated
- Sponsor
- Imperial College London
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cholecalciferol in Crohn's disease, sponsored by Imperial College London. Primary endpoint: Primary efficacy endpoint. Started Mar 2008; status: terminated.
02
Drugs
cholecalciferol
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2008-001466-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001466-93.